Biankin A V, Kench J G, Morey A L, Lee C S, Biankin S A, Head D R, Hugh T B, Henshall S M, Sutherland R L
Cancer Research Program, Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, NSW 2010 Australia.
Cancer Res. 2001 Dec 15;61(24):8830-7.
Pancreatic cancer (PC) is thought to develop through a series of duct lesions termed pancreatic intraepithelial neoplasia (PanIN). Characterization of the molecular pathology of these lesions may lead to additional understanding of pancreatic ductal carcinogenesis. We examined the protein expression of four functionally related genes, p21(WAF1/CIP1) (CDKN1A), p53, cyclin D1 (CCND1), and DPC4/Smad4 (MADH4), aberrations of which are associated with PC, within 451 PanIN lesions present in the pancreata of 60 patients. p21(WAF1/CIP1) overexpression was present in the normal ducts of 9% of patients and increased progressively to 16% of patients with PanIN-1A lesions, to 32% of patients with PanIN-1B lesions, 56% of patients with PanIN-2 lesions, 80% of patients with PanIN-3 lesions, and 85% of patients with invasive carcinomas (P < 0.01). p53 and cyclin D1 overexpression occurred predominantly in PanIN-3 lesions (P < 0.01), and loss of DPC4/Smad4 expression occurred predominantly in PanIN-3 lesions and invasive carcinoma (P < 0.01). In addition, p21(WAF1/CIP1) overexpression occurred independently of p53 and DPC4/Smad4 expression within invasive carcinoma and PanIN-3 lesions. Cyclin D1 overexpression or loss of DPC4/Smad4 expression was apparent in 85% of invasive carcinomas but in only 14% of PanIN-2 lesions. These data demonstrate that overexpression of p21(WAF1/CIP1) occurs early in the development of PanIN, before aberrations in p53, cyclin D1, and DPC4/Smad4 expression. p21(WAF1/CIP1) overexpression, independent of p53 and/or DPC4/Smad4 expression, may reflect increased Ras activity, either directly through activating K-ras mutations or as a consequence of HER-2/neu (ERBB2) overexpression, both of which are common in PC and in early events in the development of PanIN. These data support further the current progression model for PC and demonstrate that aberrant expression of key cell cycle regulatory genes may be important in the early development and progression of PanIN.
胰腺癌(PC)被认为是通过一系列称为胰腺上皮内瘤变(PanIN)的导管病变发展而来。对这些病变的分子病理学特征进行研究可能会增进对胰腺导管癌发生过程的理解。我们检测了60例患者胰腺中451个PanIN病变内4个功能相关基因p21(WAF1/CIP1)(CDKN1A)、p53、细胞周期蛋白D1(CCND1)和DPC4/Smad4(MADH4)的蛋白表达情况,这些基因的异常与胰腺癌相关。9%患者的正常导管中存在p21(WAF1/CIP1)过表达,在PanIN - 1A病变患者中逐渐增至16%,在PanIN - 1B病变患者中为32%,在PanIN - 2病变患者中为56%,在PanIN - 3病变患者中为80%,在浸润性癌患者中为85%(P < 0.01)。p53和细胞周期蛋白D1过表达主要发生在PanIN - 3病变中(P < 0.01),DPC4/Smad4表达缺失主要发生在PanIN - 3病变和浸润性癌中(P < 0.01)。此外,在浸润性癌和PanIN - 3病变中,p21(WAF1/CIP1)过表达独立于p53和DPC4/Smad4表达。85%的浸润性癌中存在细胞周期蛋白D1过表达或DPC4/Smad4表达缺失,但在PanIN - 2病变中仅为14%。这些数据表明,p21(WAF1/CIP1)过表达发生在PanIN发展的早期,早于p53、细胞周期蛋白D1和DPC4/Smad4表达异常。独立于p53和/或DPC4/Smad4表达的p21(WAF1/CIP1)过表达可能反映了Ras活性增加,这可能是直接通过激活K - ras突变,或者是HER - 2/neu(ERBB2)过表达的结果,这两者在胰腺癌以及PanIN发展的早期事件中都很常见。这些数据进一步支持了当前胰腺癌的进展模型,并表明关键细胞周期调节基因的异常表达可能在PanIN的早期发展和进展中起重要作用。